Copper homeostasis in eukaryotes: Teetering on a tightrope  by Balamurugan, Kuppusamy & Schaffner, Walter
Biochimica et Biophysica Acta 1763 (2006) 737–746
www.elsevier.com/locate/bbamcrReview
Copper homeostasis in eukaryotes: Teetering on a tightrope
Kuppusamy Balamurugan, Walter Schaffner ⁎
Institute of Molecular Biology, University of Zurich, Winterthurerstrasse 190, CH-8057, Switzerland
Received 5 January 2006; received in revised form 28 April 2006; accepted 5 May 2006
Available online 12 May 2006Abstract
The transition metal copper is an essential trace element for both prokaryotes and eukaryotes. However, intracellular free copper has to be
strictly limited due to its toxic side effects, not least the generation of reactive oxygen species (ROS) via redox cycling. Thus, all organisms have
sophisticated copper homeostasis mechanisms that regulate uptake, distribution, sequestration and export of copper. From insects to mammals,
metal-responsive transcription factor (MTF-1), a zinc finger transcription factor, controls expression of metallothioneins and other components
involved in heavy metal homeostasis. In the fruit fly Drosophila, MTF-1 paradoxically acts as an activator under both high and low copper
concentrations. Namely, under high copper conditions, MTF-1 activates metallothioneins in order to protect the cell, while under low copper
conditions MTF-1 activates the copper importer Ctr1B in order to acquire scarce copper from the surroundings. This review highlights the current
knowledge of copper homeostasis in eukaryotes with a focus on Drosophila and the role of MTF-1.
© 2006 Elsevier B.V. All rights reserved.Keywords: Copper scarcity; Copper importers; Ctr1B; Copper load; Metallothioneins; Copper detoxification; MTF-11. Biological importance of copper
Copper is an essential trace element that plays a vital role as a
catalytic co-factor for a variety of metalloenzymes including
superoxide dismutase (for protection against free radicals),
cytochrome c oxidase (mitochondrial electron transport chain),
tyrosinase (pigmentation), peptidylglycine alpha-amidating
mono-oxygenase (PAM) (neuropeptide and peptide hormone
processing) and lysyl oxidase (collagen maturation) [1–3]. At
the same time, copper is toxic to both eukaryotic and
prokaryotic cells, not least due to its ability to catalyze, via
the so-called Fenton reaction, the generation of aggressive free
radicals. Also by binding ectopically to proteins, copper can
disturb their structure [4–7]. Therefore, every organism has a
number of elaborate mechanisms at its disposal to control
cellular uptake, distribution, detoxification and elimination of
copper [8–11]. Our understanding of the systems that maintain
copper homeostasis has improved considerably with the
characterization of prokaryotic and eukaryotic copper transpor-
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doi:10.1016/j.bbamcr.2006.05.001the characterization of copper chaperones, a group of proteins
required for binding to imported copper and delivering it to
specific target proteins within the cell [1,8–13]. In this review
we attempt an overview of the mechanisms that ensure copper
homeostasis in various organisms, especially in the fruit fly
Drosophila. Defects in any of these mechanisms can have dire
consequences, as demonstrated by experimental manipulation
in genetic model organisms and by the naturally occurring
genetic defects in humans that cause severe, if not deadly
diseases such as Menkes disease and Wilson disease [14–17].
2. Copper-associated diseases
Ingested metallic copper is hardly toxic due to its in-
solubility, and toxicosis is usually caused by contaminating
traces of arsenic or lead [18]. However, inhalation of copper
dust from industrial processes causes “copper fever”, a
condition reminiscent to zinc fever. Initial symptoms are a
sweetish taste in the mouth, dryness of the throat and a burning
sensation in the eyes, followed after a few hours by strong
headache, leukocytosis, general fatigue and catarrhic symp-
toms. If the copper source is removed, symptoms disappear
within days although high copper levels remain in the blood and
Table 1
Genes involved in Drosophila copper homeostasis
Biological function Genes (homologs in
yeast/mammals)
References
Copper uptake Ctr1A, Ctr1B, Ctr1C
(yCtr1-3/hCtr1, hCtr2)
[37,40,42,51]
Copper
chaperones/
trafficking
CG32446 (Atx1/Atox1)
CCS (yCCS/hCCS)
CG9065 (yCox17/hCox17)
[42,58,59,60,84,85]
Copper transport/
efflux
DmATP7
(Ccc2/ATP7A, ATP7B)
[10,13,37,42,74,84,85]
Copper
sequestration/
detoxification
Mtn A (major role) 1
(“Cup1”/“MT-I, MT-II”) 2
[54,88,94]
Metalloregulatory
protein
dMTF-1
(“Ace1”, “Mac1”/MTF-1) 3
[11,42,51,54,107,108,110]
1 MtnB, MtnC and MtnD play minor roles in copper homeostasis.
2 Since the primary sequence of metallothioneins is so divergent between
yeast, Drosophila and mammals, that metallothionein genes might have evolved
independently (but all with role as metal scavengers).
3 In yeast, two transcription factors unrelated to MTF-1, designated Ace1 and
Mac1, handle high and low copper, respectively.
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sulfate, copper is relatively harmless considering its potential to
wreak intracellular havoc [18]. This is due to elaborate cellular
scavenging and excretion mechanisms [8–12,21]. Several
human disorders result from imbalance of copper homeostasis,
due to chronic copper deficiency or overload, and/or genetic
predisposition [14–17,22–27]. They include Menkes disease,
Wilson disease [14,22], Indian childhood cirrhosis [23],
Endemic Tyrolean infantile cirrhosis (due to cow's milk
contaminated with copper from untinned copper or brass
vessels) [24], and idiopathic copper toxicosis (an autosomal-
recessive inherited defect in copper metabolism combined with
excess dietary copper) [25]. The metabolism of copper and iron
is linked from yeast to mammals via copper-containing
ferroxidases. For example, the genetic disease aceruloplasmi-
nemia, caused by the lack of ceruloplasmin, a multicopper
ferroxidase, results in severe iron deficit and anemia [26]. In
Menkes and Wilson disease the genes affected, ATP7A and
ATP7B, respectively, have been characterized in great detail (see
below). In dogs, it was shown that mutation of the Murr1/
COMMD1 gene is associated with copper accumulation,
resulting in liver cirrhosis [27]. Intriguingly, COMMD1
interacts with the copper transporter ATP7B and also with
XIAP (X-linked inhibitor of apoptosis protein), a copper-
binding protein that can regulate COMMD1 levels via
ubiquitination [28,29]. Independently of COMMD1, the
activity of XIAP is regulated by copper binding which results
in loss of caspase inhibition and thus a lowered threshold for
apoptotic cell death [29].
A deficiency of bioavailable copper in the brain may
contribute to the pathogenesis of neurodegenerative disorders,
notably Alzheimer's disease (AD) [30,31]. Reduced activities
of several cuproenzymes such as cyclooxygenase (COX), Cu,
Zn-superoxide dismutase (SOD1) and peptidylglycine alpha-
amidating mono-oxygenase (PAM) are observed in the brain of
Alzheimer patients [32–34]. Abnormalities in copper homeo-
stasis are also associated with spongiform encephalopathies,
commonly referred to as prion diseases, and probably
Parkinson's disease [31,35]. A cancer connection of copper is
suggested by the recent finding that the cuproenzyme lysyl
oxidase is required for hypoxia-induced metastasis [36].
3. Uptake
3.1. Copper importers in yeast and mammals
From yeast to humans, copper is acquired by high affinity,
membrane-associated copper importers exemplified by the
copper transporter(Ctr)-family. Copper exists in two oxidation
states, namely, Cu(I) and the more stable oxidized form Cu(II).
Cu(I) is the substrate for the Ctr family members which are
relatively small proteins containing three transmembrane
domains [37–42]. A conserved feature of some Ctr importers
is an N-terminal segment that contains one or more “Mets”
motifs (MxxM or MxM) which have been shown by deletion
studies in yeast and human cells to be important for survival
under copper starvation. These “Mets” motifs are part of theextracellular domain and are involved in the acquisition of
copper ions for facilitated import [37,43,44]. There is evidence
that functional Ctr importers form a trimeric complex [37,42–
45]. Unlike some other high affinity metal transporters (such as
ATP7, see below), Ctr proteins do not require ATP for copper
import [37,46]. Their transport ability is stimulated by
extracellular K+ and probably facilitated by the extremely low
intracellular concentration of free copper; while the concentra-
tion of intracellular total copper is approximately 10 to 100
micro molar, free copper, e.g., copper not bound to proteins, is
several orders of magnitude lower due to an instant association
of imported copper with chaperones, scavengers and other
proteins [37,46,47]. In yeast, three copper transporters termed
yCtr1, yCtr2 and yCtr3 have been described ([21,42,45,48],
Table1). yCtr1 and yCtr3 are functionally redundant, plasma
membrane-integrated, high-affinity copper transporters. Extra-
cellular copper, usually Cu(II), has to be reduced to Cu(I) by
plasma membrane reductases encoded by FRE1 and FRE2
before being imported by yCtr1 and yCtr3 [11,21,37,42,45,46].
Any excess copper is sequestered in the vacuole (somewhat
analogous to the mammalian lysosome), a storage container of
yeast for substances intended for recycling/degradation, includ-
ing valuable metabolites such as phosphate, selected amino
acids, metals, and sequestered toxins [49]. yCtr2 is localized in
the vacuolar membrane and upon copper depletion, imports
copper from the vacuole to the cytoplasm. Thus yCtr2 also plays
an important role in yeast copper homeostasis [48]. The
function of all of these copper importers was characterized by
specific mutagenesis and by targeted gene disruption (see
below) [21,37–40,42–46].
Complementation studies in yeast for the defective copper
uptake phenotype of yctr1 and yctr3 double mutant led to the
identification of Ctr homologs in human [37,39]. Human cells
contain two Ctr proteins, designated hCtr1 and hCtr2. hCTR1 is
a 190 amino acid protein with three transmembrane domains
and is the main cellular copper importer. Similar to yCtr1, the
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cytoplasmic. Both hCtr1 and hCtr2 contain a conserved,
C-terminal motif of cysteines and histidines termed the HCH
motif [37,39,46]. Recent findings indicate that cysteine-189 of
this HCH motif is important for trimerization of hCtr1 which is
essential for function [50]. In this contest, it is worth mentioning
that hCtr1, but not its paralog hCtr2, is able to complement the
defective copper uptake phenotype of the yctr1 and yctr3
double mutant. Although hCtr2 is ubiquitously expressed at the
mRNA level, its function awaits to be elucidated [37,39].
3.2. Copper importers in Drosophila
Drosophila also contains three copper transporters of the
Ctr1-family (Ctr1A, B and C), each with a specific expression
pattern ([40]; Table 1). Ctr1A is constitutively expressed at all
stages, from four-hour-old embryos to adults and also in cultured
S2 cells from Drosophila. Ctr1B is abundantly expressed in late
embryonic stages and in larvae, but less in early embryonic
stages and adults. Unlike Ctr1A, Ctr1B and Ctr1C are not
detectable in S2 cell culture. Ctr1C expression is confined to late
larval stages and, interestingly, to adult males. These expression
patterns suggest that Ctr1 genes have distinct roles in copper
homeostasis in Drosophila [40]. By analogy to yeast copper
importers (see below), Ctr proteins in Drosophila may localize
to different cell compartments. So far, it is known that in
intestinal cells Ctr1B is localized to the apical side of the plasma
membrane, where it is responsible for copper uptake in the larval
gut ([40,42,51]; D. Egli, K.B. and W.S., unpublished data). The
Ctr1B gene is transcriptionally activated upon copper starvation
[40], and it was shown that this transporter is regulated via the
same transcription factor (MTF-1) that otherwise regulates the
activation of metal scavengers upon copper load [51] (see also
below). Besides an uptake via specific Ctr importers, copper can
also be imported by less specific general metal transporters
[37,42]. However, as shown in yeast and Drosophila, these
transporters can only ensure a sufficient copper supply when
dietary copper is abundant, and thus are unable to substitute for a
loss of Ctrs [12,21,37–40,42,46,49,51].
3.3. Lessons from deletion and overexpression of copper
importers
Menkes disease not withstanding, which is characterized by
severe copper deficiency in most organs due to malabsorption,
there are no known hereditary diseases with symptoms
resembling copper starvation. However, genetically manipulat-
ed model organisms have provided ample evidence for the
important role of copper homeostasis. In yeast, elimination of
yCtr1 copper transporter causes defects both in copper uptake
and, indirectly, in iron uptake, due to the fact the copper-
dependent ferroxidase Fet3p is essential for iron uptake
[21,42,52]. Ctr1 deletion by itself does not lead to intracellular
copper deprivation, but deletion of both yCtr1 and yCtr3 does
[1,21,42,52,53]. In higher eukaryotes, the most detailed studies
were performed in Drosophila. The phenotype of Ctr1B
mutants was akin to that of a deletion of the regulatory proteinMTF-1: Ctr1B mutants are particularly sensitive to copper
scarcity and, to a lesser extent, also to copper load [40,51,54].
The opposite genetic condition, namely, overexpression of
Ctr1B, resulted in a hypersensitivity to copper such that the flies
were not viable when grown on food of normal copper content
[51]. Interestingly, this latter phenotype was rescued by dietary
copper starvation. Expression of Ctr1B under the control of the
eye-specific promoter (GMR) resulted in aberrantly developed
eyes (“rough eye” phenotype) and this phenotype was
aggravated by copper supplementation in a dose-dependent
manner. Again, limiting dietary copper rescued the develop-
mental toxicity phenotype (H. Hua andW.S., unpublished data).
A rescue effect was also seen upon overexpression of proteins
with a role in metal detoxification (metallothioneins, MTF-1,
DmATP7; see below) (D. Egli, K.B. and W.S., unpublished
data). Knockout mice for the copper transporter Ctr invariably
die at mid-gestation, underlining the essential function of Ctr1
in copper acquisition during mammalian embryonic develop-
ment [55,56]. Unlike the congenital zinc deficiency disorder
Acrodermatitis enteropathica, which can readily be treated by
extra doses of dietary zinc, the Ctr knockout cannot be rescued
by extra copper supply to the pregnant female [55–57].
4. Distribution
4.1. Delivery of copper: copper chaperones
In contrast to zinc, which is required as a structural or
catalytic co-factor in hundreds of proteins, copper is part of a
considerably lower number of proteins. This fact, combined
with the extreme toxicity of free intracellular copper, is
probably the reason why organisms from prokaryotes to
mammals are in possession of specific copper chaperones that
bind copper with high affinity and deliver it to specific target
proteins. They are probably important also to compete with the
non-specific copper binding sites of many cellular proteins in
various subcellular compartments. From yeast to humans, three
functional groups of chaperones are conserved ([58–60], Table
1). Atx1 is a cytosolic yeast chaperone that delivers copper to
the transport ATPase Ccc2 in the trans-Golgi network. From
there, Ccc2 translocates copper into vesicles where it is loaded
into the multicopper containing protein ferroxidase Fet3 [61].
The human homolog of Atx1, Atox1, delivers copper to
Menkes and Wilson disease ATPase transporters ATP7A (or
MND) and ATP7B (or WND), respectively. While ATP7A
delivers copper to copper-dependent enzymes in the secretory
pathway, ATP7B directs copper incorporation into ceruloplas-
min, a serum ferroxidase that contains more than 95% of the
copper found in blood plasma ([62,63], see also Section 4.2).
ATP7A, also called Menkes disease protein, directs copper
within the trans-Golgi network to several cupro-enzymes
including tyrosinase ([10,13,37]; Fig. 1). A bacterial homolog
of Atx1 called CopZ, has also been identified [64]. The copper
chaperones for superoxide dismutase, referred to as CCS
proteins, donate copper to the eukaryotic antioxidant enzyme
Cu,Zn-superoxide dismutase (SOD1) [65]. Mice with a
targeted disruption of CCS exhibit marked reductions in
Fig. 1. Schematic view of copper homeostasis in Drosophila. At low copper conditions (top), dMTF-1 does not activate metallothionein gene transcription and
analogous to mammalian MTF-1, preferentially localizes to the cytoplasm. Nevertheless, dMTF-1 still binds to MREs of the Ctr1B upstream enhancer/promoter and
activates transcription of the Ctr1B gene. Ctr1B imports copper in the form of Cu(I) ions which are shuttled to copper-containing proteins by means of the copper
“chaperones” (Atx1, CCS, and Cox17). At conditions of copper excess (bottom), more MTF-1 is recruited to the nucleus. In spite of persisting MTF-1 binding,
transcription of the Ctr1B gene is attenuated, possibly by an unknown copper-dependent repressor (shown in red), whereas metallothionein genes are strongly
transcribed. The copper efflux transporter ATP7, by changing its subcellular localization, removes excess copper from the cell. Several aspects, such as the role of
copper chaperones, and the translocation of ATP7 to the outer cell membrane upon copper load, are extrapolated from findings in yeast and mammals, respectively.
Note however, that some details may not be conserved between species; for example, in mammals, SOD1 can (also) be loaded by a copper–glutathione complex [124].
For simplicity, the chaperone designations are taken from yeast, rather than the gene annotation numbers of Drosophila (Atx1, Cox17 and Sco1 instead of CG32446,
CG9065 and CG8885, respectively).
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mechanism has been elucidated to a large extent. CCS has a
structure that resembles the copper binding domain of SOD
and mediates the formation of a transient heterodimer between
CCS and SOD. This heterodimer resembles the SOD
homodimer and facilitates copper transfer to SOD [67].
Three proteins, Cox17, Cox11 and Sco1, play a role in the
assembly of mitochondrial cytochrome c oxidase [68]. Cox17
is proposed to deliver copper to the inner mitochondrial
membrane proteins Cox11 and Sco1, which in turn may
transfer it to cytochrome c oxidase (Cco) ([42,68,69], see also
Fig. 1). Some fungi such as Podospora anserina are able tomaintain respiration even upon insufficient copper supply,
switching from COX to AOX, an iron-containing alternative
oxidase [70]. From yeast to humans, several studies have
shown that Cu(I) forms a binuclear cluster (cuprous-thiolate)
intermediate with the cysteine residues of chaperones such as
yCox17 and hCCS [71–73].
4.2. Copper-transporting P-type ATPases
Unlike yeast, multicellular organisms have the additional
problem that copper not only has to be taken up by cells of the
digestive tract, but that there also has to be an adequate copper
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aforementioned ATP-dependent transporters of the ATP7
family. These heavy-metal-transporting P-type ATPases are
conserved from bacteria to mammals ([10–13,74,75], Table 1),
whereby the latter contain two isoforms termed ATP7A and
ATP7B. ATP7A is expressed in the intestinal epithelium as well
as most other tissues other than liver. Both ATP7A and ATP7B
undergo copper-stimulated trafficking [10,13,14,76–78]. At
elevated copper levels, ATP7A, i.e., Menkes disease protein
moves from the trans-Golgi network to the plasma membrane
and redistributes excess copper by pumping out from the cell.
ATP7A returns to the trans-Golgi network as soon as the
intracellular copper levels are reduced. ATP7A, which is also
expressed in mucosal cells lining the intestine, is pivotal for
systemic absorption of copper in these cells as well as
reabsorption in the kidneys [10,13,22,77,79]. ATP7A is
particularly important for adequate copper supply to the brain
and any impairment in the activity of this protein leads to the
very severe Menkes disease, an X-linked recessive disorder that
presents with symptoms including stunted growth, skeletal
defects and progressive degeneration of the central nervous
system, often fatal during early childhood [10,14,22,77].
Vertebrates including humans possess ATP7B, a liver-
specific copper transporter that also plays a central role in the
transport of copper across cellular membranes [10,13,14,74].
ATP7B is normally expressed in liver and kidney and to a lesser
extent in the brain. It is structurally and functionally related to
ATP7A and the two corresponding genes must have arisen by
duplication [80].Normally ATP7B, like ATP7A in other tissues,
is involved in transporting copper into the secretory pathway for
incorporation into apoceruloplasmin in the trans-Golgi network.
At high copper load, ATP7B trafficks to the biliary canalicular
membrane where excess copper is excreted into the bile duct
for disposal from the body via digestive tract [10,13,22,74,
79,81,82]. Loss-of-function mutations in the ATP7B gene leads
to Wilson disease, an autosomal recessive disease which causes
accumulation of copper in the liver and a life-threatening liver
cirrhosis due to a deficiency of biliary copper secretion [10,13,
22,74,82]. Besides liver cirrhosis, Wilson disease can also
present with neurological symptoms such as behavioral dis-
turbances and movement disorders [22,82,83].
Drosophila has a sole ortholog of mammalian Menkes and
Wilson genes, DmATP7, which is essential for in vivo copper
distribution. Recent studies have shown that DmATP7 plays at
least two roles at the cellular level: i) delivering copper to cupro-
enzymes required for pigmentation and neuronal function, and
ii) removing excess cellular copper via facilitated efflux [84,85].
Similar to Menkes disease, the loss of this ATPase gene in
Drosophila results in hyperaccumulation of copper in intestinal
cells but copper starvation in the rest of the body [85].
5. Detoxification/elimination
5.1. Metallothioneins: a safeguard of the cell
Even though copper export and import are subject to
elaborate control mechanisms, there can be conditions wherecopper is imported in excess. For example, Drosophila Ctr1B,
the major larval copper importer, is regulated at the transcrip-
tional level while in other species the Ctrs are regulated
posttranscriptionally. However, both downregulation mechan-
isms may not be fast enough to cope with a sudden increase in
ambient copper concentration ([51,86], D. Egli, K.B. and W.S.,
unpublished data). Therefore, an important aspect of metal
homeostasis is the sequestration of toxic heavy metals,
especially copper, a task that is mainly performed by the
metallothioneins. Metallothioneins constitute a group of low
molecular weight, cysteine-rich proteins with outstanding metal
binding capacity [87,88]. They are found in all eukaryotes as
well as in some prokaryotes and mainly function as metal
scavengers/metal storage proteins ([54,89–92]; Table 1).
Typically metallothionein genes are expressed at a basal level
but their transcription is strongly induced upon heavy metal
load [54,91,92]. Even though metallothioneins are the least
conserved of the proteins described in this review (importers,
exporters, chaperones, transcription factors, scavengers), they
share the common feature of a very high proportion of cysteines
which enables them to avidly bind toxic metals while also
playing a role in cellular redox balance and radical scavenging.
Budding yeast Saccharomyces cerevisiae contains two metal-
lothioneins, Cup1 and CRS5 [93,94]. These are copper-
thioneins and their inactivation leads to copper sensitivity,
while their overexpression confers resistance to copper toxicity
[93–95]. Of the two, Cup1 seems to play a dominant role in
neutralizing excess intracellular copper [94]. In Drosophila,
there are four metallothioneins, namely, MtnA, MtnB, MtnC
and MtnD [54]. MtnA is primarily expressed during embryo-
genesis, while MtnB is found in late stage embryos, larvae, and
in adult flies within the gut, Malpighian tubules, fat body and
hemocytes [96–98].MtnC andMtnD have arisen most likely by
duplications from the MtnB gene and have a lesser role in
protecting against metal toxicity [54,99]. Drosophila mutants
with a disruption of all four metallothionein genes (“family
knockout”) are highly sensitive to elevated copper concentra-
tions [99]. Interestingly, metallothionein expression and the
sites of copper accumulation coincide, especially in the
cytoplasm of so-called copper cells of the midgut and also in
the posterior midgut [100,101]. These copper cells, or
cuprophilic cells, upon copper load display a peculiar orange
copper luminescence caused by a copper–metallothionein
complex. This copper luminescence rapidly disappears if larvae
are transferred to copper-depleted food, presumably because
copper is provided to the growing organism [99,102].
In vertebrates, the metallothioneins are small proteins but
still larger than those of Drosophila and yeast. Among the
approximately 60 amino acids of a typical vertebrate metal-
lothionein, close to one third are cysteines. All mammals
contain four major members of the metallothionein family,
termed MT-I to MT-IV (or MT-1 to MT-4) [87,88]. In the
mouse, each type is represented by one member, while in
humans, MT-I has expanded into a gene family of its own. MT-I
and MT-II are expressed at all stages of development in most, if
not all cell types. Their transcription is responsive to adverse
conditions, especially heavy metal load, oxidative stress,
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[87,88,91,103]. MT-III is constitutively expressed, predomi-
nantly in neurons but also in glia and male reproductive organs,
and its elimination in the mouse increases susceptibility to
seizures [104]. MT-IV expression is confined to differentiated
squamous epithelia [105]. The MT-IV gene, which also contains
a metal response element (MRE) in the promoter region, is at
least partially metal responsive [105].
5.2. Metallothioneins and ATPase transporters handle excess
cellular copper
Metallothioneins share a high cysteine content and the
property to avidly bind heavy metals but otherwise can be quite
divergent in their primary sequence. Nevertheless, vertebrate
metallothioneins from fish to humans display sequence
similarity, which suggests that apart from sequestering heavy
metals, they also play additional role(s) by interacting with
specific cellular proteins [87,88,91,103,106,107]. While the
role of metallothioneins in metal detoxification is established
beyond doubt, not least by the complete knockout of all four
Drosophila family members [99,102], metallothioneins proba-
bly serve as a metal source during a transient metal scarcity.
However, a detailed analysis of Drosophila knockout flies has
not provided any evidence that a lack of metallothioneins wouldFig. 2. Overview of the transcription factors regulating copper homeostasis in diff
proteins are involved in maintaining copper levels: Mac1 at low copper and Ace1 at hi
handled solely via dMTF-1, the homolog of mammalian MTF-1 (metal-resp
posttranscriptionally; therefore, copper-regulated transcription factors may not be inreduce fitness under chronic copper starvation. In line with the
latter finding, metallothionein expression is strongly diminished
in wild type flies under limiting copper conditions [51,99].
Metallothioneins can store copper but they are not suitable
to eliminate an excess of it from the cell. For this, there are
the aforementioned ATP7 transporters, which in some
multicellular organisms redistribute copper from one cell to
another but do not affect total body copper. In vertebrates, as
mentioned before, there is nevertheless a specific way of
eliminating excess copper from the organism utilizing the
liver-specific ATP7B Wilson transporter, which upon copper
load translocates from the Golgi to the plasma membrane to
export copper into the so-called canaliculi, the smallest bile
transport channels that ultimately lead into the gall bladder
[10,13,74,77,79,82].
6. Transcriptional regulation of copper homeostasis: from
yeast to mammals
As mentioned, the expression of metallothioneins is
regulated at the transcriptional level. Upon heavy metal load,
specific metal-responsive transcription factors bind to metal-
lothionein gene promoters to boost their expression. In the
budding yeast S. cerevisiae, the responsible factor is Ace1. The
amino-terminal half of Ace1, which is rich in cysteines anderent organisms. In the yeast Saccharomyces cerevisiae, two copper-regulated
gh copper. InDrosophila, the response to both copper load and copper scarcity is
onsive transcription factor-1). In humans, copper importers are regulated
volved (see text).
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DNA binding domain. The carboxyl-terminal half is highly
acidic in nature and mediates contacts to the transcription
apparatus [108,109]. In the yeast metallothionein gene
promoters, Ace1 binds to cis-regulatory elements (UASCu,
core consensus sequence 5′-GCTG-3′) that mediate transcrip-
tional activation by copper [108,109]. For the converse si-
tuation of copper starvation, yeast relies on Mac1, a distinct
transcription factor. Mac1 is also regulated by copper, whereby
the copper-binding domain acts as an intramolecular auto-
inhibitory domain [110–112]. Curiously, in the fission yeast
Schizosaccharomyces pombe, Cuf1, a factor more closely
related to S. cerevisiae Ace1 than to Mac1, is activated by
copper starvation [113]. From insects to mammals, the main
transcription regulator for handling heavy metal load, including
copper excess, is MTF-1 (metal-responsive element binding
transcription factor-1 or metal-responsive transcription factor-1)
(see below) (Table 1 and Fig. 2) [54,107,114–117].
6.1. MTF-1 in mammals and Drosophila
MTF-1 and its cognate binding site, metal-response ele-
ment (MRE, core consensus TGCRCNC) of higher eukar-
yotes is the functional analog of yeast Ace1, but neither the
two factors nor their binding sites are related to each other
[107–112]. The DNA binding domain of MTF-1 consists of
six zinc fingers of the C2H2 type. Several studies have shown
that MTF-1 requires a higher zinc concentration than other
factors for DNA binding in vitro, which suggested a simple
mode of activation by metal load [118,119]. Indeed, in a cell-
free transcription system, it was shown that zinc activates
human MTF-1 directly, whereas copper, cadmium, and
hydrogen peroxide activate transcription indirectly by displa-
cing zinc from zinc-saturated metallothioneins and probably
also from other zinc binding cellular proteins [118,119].
However, this in vitro system does not reproduce the full
complexity of the in vivo regulation of MTF-1, which also
involves phosphorylation/dephosphorylation and nucleo-
cytoplasmic shuttling [120,121]. Human MTF-1 contains an
extended non-canonical nuclear localization signal (NLS)
sequence that overlaps with the zinc finger domain (M.
Cramer, M. Meuli, O. Georgiev and W.S., unpublished). The
C-terminal part of MTF-1 downstream of the zinc fingers
harbors three different transactivation domains, namely, an
acidic, a proline-rich, and a domain rich in serine and
threonine [107,122]. MTF-1 also contains a conserved nuclear
export signal (NES) sequence (LCLSDLSLL) overlapping
with the major activation domain [120]. In non-dividing, non-
stressed cells, the majority of MTF-1 is located in the
cytoplasm. Upon heavy metal load, MTF-1 accumulates in
the nucleus and activates transcription of its target genes via
binding to MREs in the promoters [107,120]. It has been
shown that the NES is essential for metal activation of human
MTF-1 (M. Cramer and W.S., unpublished). Also, metal
induction is blocked by broad range inhibitors of protein
kinase C, which indirectly cause elevated phosphorylation of
MTF-1. This suggests that specific dephosphorylation ofMTF-1 might contribute to its activation [121]. Both human
and Drosophila MTF-1 are highly conserved in the DNA
binding zinc finger region but vary considerably outside of it
[116,123]. Complementation studies have shown that both the
human and Drosophila MTF-1 are partially metal responsive
when introduced into flies and mammalian cells devoid of
their endogenous MTF-1, respectively [123].
6.2. Paradoxical activity of dMTF-1
MTF-1 is a unique transcription factor in that it is able to
handle both extremes, namely, copper load and copper
starvation. At high copper it activates metallothionein genes,
while at low copper it activates the gene for the copper importer
Ctr1B. The upstream region of the Ctr1B gene, which mediates
transcriptional induction upon copper scarcity, includes a
segment with three uniquely spaced, strong MREs that is
highly conserved among several Drosophila species. These
MREs are bound by MTF-1 both at low and high copper, and
due to their specific arrangement, possibly in conjunction with
auxiliary factors, confer activity upon copper starvation [51]
(Figs. 1 and 2).
WhileDrosophila Ctr1B is predominantly, if not exclusively,
regulated at the transcriptional level ([51]; D. Egli, K.B. and
W.S., unpublished data), yeast and human Ctrs are regulated
posttranscriptionally, whereby excess copper was reported to
stimulate rapid protein degradation and/or endocytosis
[37,43,53,86]. Each of these mechanisms, whether transcrip-
tional or posttranscriptional, allows for a fine tuning of Ctr
levels and thus of copper import.
7. Conclusions
The data presented in this review emphasize the vital
importance of copper homeostasis for all eukaryotes. While
studies in yeast have paved the way for similar studies in
multicellular organisms, important insights were also obtained
from human copper-associated diseases and their mouse
models. Copper homeostasis in the fruit fly Drosophila has
only recently been studied intensely but the results have
already contributed significantly to the field. In spite of
considerable insights into the mechanisms regulating copper
levels obtained in recent years, our understanding is far from
complete. In Drosophila, for example, it is not clear whether
there are copper-responsive repressor(s) and/or coactivator(s)
of the transcription regulator MTF-1. Another question
concerns the specificity of the metal response. For example,
why is the Ctr1B copper importer only activated upon copper
starvation, the zinc exporter Znt-35C only by excess zinc, but
the metallothionein genes by most heavy metals? What is the
overlap, if any, in the roles of the three copper importers
Ctr1A, Ctr1B and Ctr1C? In humans, major questions
concern the involvement of copper in neurodegenerative
diseases such as Alzheimer, Parkinson and prion diseases.
Answers to these questions will be of great medical
importance and will have to come from a combination of
clinical research and work with model organisms. The latter
744 K. Balamurugan, W. Schaffner / Biochimica et Biophysica Acta 1763 (2006) 737–746will not only include mammals, especially mice, but also
Drosophila, C. elegans and even yeast, thanks to the
conservation of several of the basic mechanisms.
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